BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6779307)

  • 1. D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.
    Tortella FC; Moreton JE
    Psychopharmacology (Berl); 1980; 69(2):143-7. PubMed ID: 6779307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and postdependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):344-51. PubMed ID: 7197301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administration of an enkephalin analog by rhesus monkey.
    Mello NK; Mendelson JH
    Pharmacol Biochem Behav; 1978 Nov; 9(5):579-86. PubMed ID: 104309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
    Khazan N; Young GA; Calligaro D
    Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief communication. Generalization of [DAla2]-enkephalinamide but not of substance P to the morphine cue.
    Chipkin RE; Stewart JM; Morris DH; Crowley TJ
    Pharmacol Biochem Behav; 1978 Jul; 9(1):129-32. PubMed ID: 704649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites.
    Olds ME; Williams KN
    Brain Res; 1980 Jul; 194(1):155-70. PubMed ID: 7378834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peptidase inhibitors, [D-Ala2, Met5]-enkephalinamide and antiserum to methionine-enkephalin microinjected into the caudal periaqueductal gray on morphine withdrawal in rats.
    Fukunaga Y; Inoue N; Miyamoto M; Kishioka S; Yamamoto H
    Jpn J Pharmacol; 1998 Dec; 78(4):455-61. PubMed ID: 9920202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice.
    Bhargava HN
    Pharmacol Biochem Behav; 1980 May; 12(5):645-9. PubMed ID: 7190300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
    Brady LS; Holtzman SG
    J Pharmacol Exp Ther; 1982 Jul; 222(1):190-7. PubMed ID: 7201020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
    Ohlsson AE; Fu TC; Jones D; Martin BR; Dewey WL
    J Pharmacol Exp Ther; 1982 May; 221(2):362-7. PubMed ID: 6281413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of learned thermoregulatory behavior by central injection of opioids in cats.
    Clark WG; Bernardini GL
    Pharmacol Biochem Behav; 1982 Jun; 16(6):983-8. PubMed ID: 7051050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intracerebroventricular infusion of morphine, methionine-enkephalin and D-Ala2-enkephalinamide on body temperature of rabbits.
    Konecka AM; Sadowski B; Jaszczak J; Panocka I; Sroczynska I; Misicka A
    Arch Int Physiol Biochim; 1982 Apr; 90(1):1-7. PubMed ID: 6179485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerability to stressor-induced disturbances in self-stimulation from the dorsal and ventral A10 area: differential effects of intraventricular D-Ala2-Met5-enkephalinamide, D-Ala2, N-Me-Phe4, Gly-Ol5-enkephalin, and D-Pen2, D-Pen5-enkephalin administration.
    Zacharko RM; Maddeaux C; Hebb AL; Mendella PD; Marsh NJ
    Brain Res Bull; 1998 Oct; 47(3):237-48. PubMed ID: 9865856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.